← Leaderboards
John Stephen Kovach
City Of Hope/Beckman Research Institute
$2,724,190
Attributed
$2,724,190
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $94.6K · FY2005–07$100K$75K$50K$25K$0
'05
'06
'07
Funding mix
By agency
NIH$2,724,190 · 6
By mechanism
P30$2,435,220 · 3
M01$288,970 · 3
Top collaborators
No co-investigators on record.
Most similar at City Of Hope/Beckman Research Institute
Same institution · by research overlap
- James H Doroshow$6,200,078
- Joyce Carol Niland$64,803,331
- Edward M Newman$11,109,553
- Lucille Leong$684,227
Others in their field
Top investigators on “Biomedical Facility”
- David Heimbrook · Leidos Biomedical Research, Inc.$269,207,281
- Mark S Klempner · Tufts Medical Center$133,377,807
- Joseph E Robertson · Oregon Health & Science University$129,896,064
- Lee Hamm · Tulane University Of Louisiana$114,986,978
- Peter Gordon Gillespie · Oregon Health And Science University$108,298,240
- Jeffrey S Flier · Beth Israel Deaconess Medical Center$90,163,926
Research focus
Biomedical FacilityNeoplasm /CancerHuman DataBiomedical Equipment SafetyBiomedical ResourceCancer Registry /ResourceClinical TrialsDiagnosis Procedure SafetyPatient Care ManagementSafety EquipmentTrainingDisorder PreventionEarly DiagnosisFemaleFundingGrantHealth Science ProfessionHealth Science ResearchCancer Information SystemInstitutionLong IslandMalignant Neoplasm Of BreastMalignant NeoplasmsMethod Development
Grant awards (22)
PROTOCOL FOR THE LONG ISLAND DATABASE PROJECT FOR BREAST CANCER$14,977
M01 · FY2007 · RR · contact PI
PROTOCOL FOR THE LONG ISLAND DATABASE PROJECT FOR BREAST CANCER$88,602
M01 · FY2006 · RR · contact PI
PROTOCOL FOR THE LONG ISLAND DATABASE PROJECT FOR BREAST CANCER$94,647
M01 · FY2005 · RR
Protocol for the Long Island Database Project for Breast Cancer$90,744
M01 · FY2004 · RR
CORE--DEVELOPMENTAL FUNDS$135,290
P30 · FY2002 · CA
CORE--PROTOCOL SPECIFIC RESEARCH SUPPORT$135,290
P30 · FY2002 · CA
CORE--PROTOCOL SPECIFIC RESEARCH SUPPORT$135,290
P30 · FY2002 · CA
CORE--CLINICAL TRIAL PROTOCOL AND MONITORING SYSTEM$135,290
P30 · FY2002 · CA
CORE--CLINICAL TRIAL PROTOCOL AND MONITORING SYSTEM$135,290
P30 · FY2002 · CA
CORE--DEVELOPMENTAL FUNDS$135,290
P30 · FY2002 · CA
CORE--DEVELOPMENTAL FUNDS$135,290
P30 · FY2001 · CA
CORE--CLINICAL TRIAL PROTOCOL AND MONITORING SYSTEM$135,290
P30 · FY2001 · CA
CORE--PROTOCOL SPECIFIC RESEARCH SUPPORT$135,290
P30 · FY2001 · CA
CORE--CLINICAL TRIAL PROTOCOL AND MONITORING SYSTEM$135,290
P30 · FY2000 · CA
CORE--DEVELOPMENTAL FUNDS$135,290
P30 · FY2000 · CA
CORE--DEVELOPMENTAL FUNDS$135,290
P30 · FY2000 · CA
CORE--DEVELOPMENTAL FUNDS$135,290
P30 · FY2000 · CA
CORE--PROTOCOL SPECIFIC RESEARCH SUPPORT$135,290
P30 · FY2000 · CA
CORE--PROTOCOL SPECIFIC RESEARCH SUPPORT$135,290
P30 · FY2000 · CA
CORE--PROTOCOL SPECIFIC RESEARCH SUPPORT$135,290
P30 · FY2000 · CA
CORE--CLINICAL TRIAL PROTOCOL AND MONITORING SYSTEM$135,290
P30 · FY2000 · CA
CORE--CLINICAL TRIAL PROTOCOL AND MONITORING SYSTEM$135,290
P30 · FY2000 · CA